“…Moreover, eighteen patients of the 23 cases (Table 2) [3,[10][11][12][13][14][15][16][17][18][19][20][21][22][23] underwent serological assay, and antiganglioside antibodies were identified in 88.9% patients (16/18 cases). IgG anti-GT1a antibody (11, 68.8%) was the most frequent, followed by IgG anti-GQ1b (10/16, 62.5%), IgM anti-GT1a (4/16), IgM anti-GQ1b (2/16), IgG anti-GM1b (2/16), IgM anti-GM1b (2/16), IgG anti-GM2 (1/16), IgG anti-GM3 (1/16), IgG anti-GD1a (1/16), IgM anti-GD1a (1/16), IgG anti-GT1b(1/16).…”